Blog

Hearing on Biotech Medicine Prices

Posted on by Jesse Lee

The Oversight Committee is currently holding a hearing to examine the high cost of biotech medicines to our health care system, as well the prospects and need for a pathway that would allow the FDA to approve safe and affordable generic versions of biotech drugs.

Watch live and see the witness list >>

Watch Chairman Henry Waxman’s opening remarks:

Chairman Waxman:
“Some of these drugs cost each patient tens of thousands of dollars a year, some can cost hundreds of thousands per year. Many people cannot get access to these near-miracles, and even when people can get them, the prices drive up the costs of Medicare, Medicaid, and health insurance overall. Why isn’t the market helping?”
This entry was posted in Affordable Health Care, Oversight, Retirement Security. Bookmark the permalink.